Largest
epidemiological study on Diabetes and NCDs in India
Chennai:
A ground-breaking research paper of a
comprehensive epidemiological study funded by ICMR has been published in the
globally acclaimed medical journal, The Lancet Diabetes and
Endocrinology. Funded by the Indian Council of Medical Research and
Ministry of Health and Family Welfare. Govt. of India, the study paper - Indian
Council of Medical Research–India Diabetes (ICMR-INDIAB) shockingly
reveals India has a much higher burden of metabolic non-communicable
diseases (NCDs) This cross-sectional, population-based survey of
adults aged ≥20 years, sampled a total of 1,13,043 individuals (33,537 urban
and 79,506 rural residents) in 31 States and Union Territories of the country
using a stratified, multistage sampling design. In this large
representative sample of individuals from both urban and rural India, the study
measured the prevalence of metabolic NCDs such as diabetes, hypertension,
obesity, and dyslipidaemia. It also identified regional and state-level
variations in the prevalence of these NCDs across the nation.
ICMR-INDIAB study findings
|
Non-communicable
diseases (NCDs) |
National prevalence |
Estimated number of
people in India, in millions (Burden) |
State with highest
prevalence |
State with lowest
prevalence |
|
Diabetes |
11.4% |
101 |
Goa (26.4%) |
Uttar Pradesh (4.8%) |
|
Prediabetes |
15.3% |
136 |
Sikkim (31.3%) |
Mizoram (6.8%) |
|
Hypertension |
35.5% |
315 |
Punjab (51.8%) |
Meghalaya (24.3%) |
|
Generalized Obesity |
28.6% |
254 |
Puducherry (53.3%) |
Jharkhand (11.6%) |
|
Abdominal Obesity |
39.5% |
351 |
Puducherry (61.2%) |
Jharkhand (18.4%) |
|
Hypercholesterolemia |
24.0% |
213 |
Kerala (50.3%) |
Jharkhand (4.6%) |
Urban vs rural difference:
Urban regions had higher rates of
all metabolic NCDs than rural areas, with the exception of prediabetes.
New National estimates for diabetes and other NCD’s: Our study estimates that in 2021, in India there are 101 million people with diabetes and 136 million people with prediabetes, 315 million people had high blood pressure, 254 million had generalized obesity, and 351 million had abdominal obesity. Additionally, 213 million people had hypercholesterolaemia.
Dr.R.M.Anjana, Managing Director, Dr.Mohan’s Diabetes
Specialities Centre (DMDSC) and President, Madras Diabetes Research Foundation
(MDRF) commented “We at MDRF are more than proud to be spearheading this herculean task as
the national coordinating centre for the study with generous support from ICMR
and Ministry of Health, Government of India. The in-depth report is likely to
have a huge impact on the healthcare policies for the country specific to NCDs.
The findings of this study are very significant as they provide robust
estimates of NCDs for the nation. Compared to earlier estimates, India
currently has a substantially greater prevalence of metabolic NCDs. In
India, the diabetes epidemic is in transition, with some states having already
reached their peak rates while others are just getting started. The study also
demonstrates that despite the fact that all metabolic NCDs are more common in
urban regions, rural areas have significantly greater prevalence rates than
that reported previously “
”
Dr.V.Mohan, Chairman,
Dr.Mohan’s Diabetes Specialities Centre (DMDSC) and Madras Diabetes Research
Foundation (MDRF) and senior author of the study added “With dedicated and
commendable efforts by the members of MDRF, we have successfully been able to
assess the rise in NCDs like obesity, Hypertension and Diabetes which
definitely affects millions across the globe. Our study results have
multiple implications for the planning and provision of health care in India. State
governments in India, who are primarily in charge of providing healthcare in
their respective regions, will be especially interested in the detailed
state-level data on these NCDs as it will allow them to develop evidence-based
interventions to successfully halt the progression of NCDs and manage their
complications.”
Dr.R.S.Dhaliwal, Scientist ‘G’ & Head, Non-communicable Disease Division, Indian Council of Medical Research (ICMR) and Dr.Tanvir Kaur, Scientist ‘G’, NCD Division, ICMR expressed their delight and honour to have been part of this ICMR – INDIAB study which involved an extensive amount of time, effort and research in coming up with research breakthrough. Dr.R.S.Dhaliwal, Scientist ‘G’ & Head, Non-communicable Disease Division, Indian Council of Medical Research states “It is quite evident from the study results that India has a substantial population at risk of cardiovascular disease and other long-term organ complications due to metabolic NCDs. “
Being
the national coordinating centre for this study, MDRF was involved in this
detailed task of planning and executing the project successfully. Covering all
28 states, two union territories, and the national capital region of Delhi, the
survey was executed an extensive sample size of 1,13,043 individuals. The
results of the study are published in the prestigious and globally renowned
medical journal The Lancet Diabetes and Endocrinology.
Please
note that this article is embargoed until 23:30 hrs UK time on 7th
June 2023.
The post
embargo link is given below to access the article.
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00119-5/fulltext
About MDRF:
The Madras
Diabetes Research Foundation (MDRF) is a renowned research institute located in
Chennai, India. It is dedicated to conducting scientific research on diabetes
and related complications. The foundation was established in 1996 by Dr. V.
Mohan, a leading diabetologist in India. MDRF's primary focus is on
understanding the causes, prevention, and management of diabetes, as well as
its associated complications. The research conducted at MDRF encompasses
various aspects of diabetes, including epidemiology, genetics, clinical
management, and public health. MDRF plays a crucial role in advancing knowledge
about diabetes, improving patient care, and combating the growing burden of
diabetes in India and beyond.
கருத்துரையிடுக